3.46
Pluri Inc stock is traded at $3.46, with a volume of 8,997.
It is up +6.75% in the last 24 hours and up +2.35% over the past month.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
See More
Previous Close:
$3.26
Open:
$3.26
24h Volume:
8,997
Relative Volume:
0.39
Market Cap:
$30.91M
Revenue:
$1.03M
Net Income/Loss:
$-21.34M
P/E Ratio:
-0.5603
EPS:
-6.175
Net Cash Flow:
$-18.22M
1W Performance:
-7.73%
1M Performance:
+2.35%
6M Performance:
-27.19%
1Y Performance:
-32.40%
Pluri Inc Stock (PLUR) Company Profile
Name
Pluri Inc
Sector
Industry
Phone
972-74-710-7171
Address
MATAM ADVANCED TECHNOLOGY PARK, HAIFA
Compare PLUR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
PLUR
Pluri Inc
|
3.34 | 30.17M | 1.03M | -21.34M | -18.22M | -6.175 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.91 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
720.38 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
457.68 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
896.16 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
203.75 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Pluri Inc Stock (PLUR) Latest News
Is Pluri Inc. (4DX) stock worth holding before Fed meeting2025 Short Interest & Risk Adjusted Buy and Sell Alerts - Newser
Cultivated Meat Advances Gain New Momentum - Prepared Foods magazine
Can Pluri Inc. (4DX) stock sustain double digit ROEMarket Growth Report & Fast Momentum Entry Tips - Newser
Should You Hold or Sell Dilip Buildcon Limited Stock Expert PerspectivesVolume Spike Alerts & The Best Picks Hiding in Plain Sight - earlytimes.in
Should I buy Pluri Inc. (4DX) stock before earnings seasonQuarterly Growth Report & Technical Buy Zone Confirmations - Newser
Will Pluri Inc. (4DX) stock sustain dividend payoutsWeekly Trade Summary & Verified Short-Term Trading Plans - Newser
Is Pluri Inc. (4DX) stock safe for risk averse investorsWeekly Trade Analysis & Fast Moving Stock Trade Plans - Newser
Is Pluri Inc. (4DX) stock testing key supportJuly 2025 Action & Daily Profit Focused Stock Screening - Newser
Aug Summary: Will First Watch Restaurant Group Inc stock reach Wall Street targetsJuly 2025 PreEarnings & Growth Oriented Trade Recommendations - BỘ NỘI VỤ
Why Pluri Inc. (4DX) stock could break out in 2025Market Volume Report & Real-Time Sentiment Analysis - BỘ NỘI VỤ
How Pluri Inc. stock performs after earningsSwing Trade & Intraday High Probability Alerts - BỘ NỘI VỤ
Can Alchemist Corporation Limited Beat EPS Estimates in the Next QuarterIPO Market Watch & Stocks to Buy Before Earnings Season - earlytimes.in
Is Freight Technologies Inc. stock undervalued vs historical averagesPortfolio Growth Summary & Growth Focused Investment Plans - BỘ NỘI VỤ
Is Pluri Inc. stock undervalued vs historical averagesPortfolio Value Summary & Stepwise Swing Trade Plans - newser.com
Will Pluri Inc. stock split again soonPortfolio Gains Report & Verified High Yield Trade Plans - newser.com
Insider Stock Purchases: November 20, 2025 - Quiver Quantitative
Pluri Inc. director Weinstein buys shares worth $2.08 million By Investing.com - Investing.com Canada
Pluri Inc. director Weinstein buys shares worth $2.08 million - Investing.com
Will Pluri Inc. (4DX) stock see insider accumulationMarket Performance Recap & Stock Timing and Entry Methods - newser.com
How risky is Pluri Inc. (4DX) stock compared to peersQuarterly Performance Summary & Reliable Volume Spike Trade Alerts - newser.com
Is Pluri Inc. (4DX) stock considered safe haven2025 Price Targets & Free Technical Confirmation Trade Alerts - newser.com
Can Pluri Inc. (4DX) stock sustain free cash flowQuarterly Earnings Report & Entry and Exit Point Strategies - newser.com
Analyzing drawdowns of Pluri Inc. with statistical tools2025 Sector Review & Weekly High Conviction Ideas - newser.com
Using Ichimoku Cloud for Pluri Inc. technicalsBuy Signal & Accurate Entry and Exit Point Alerts - newser.com
Will Pluri Inc. stock outperform tech sector in 20252025 Earnings Impact & Precise Swing Trade Alerts - newser.com
Will Pluri Inc. (4DX) stock rise with strong economyQuarterly Profit Review & Daily Growth Stock Investment Tips - newser.com
Will Pluri Inc. stock benefit from sector rotationPortfolio Performance Summary & AI Based Buy/Sell Signal Reports - newser.com
Pluri Inc Stock (PLUR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Pluri Inc Stock (PLUR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Manieu Alexandre Weinstein | Director |
Apr 28 '25 |
Buy |
4.61 |
452,702 |
2,086,956 |
452,702 |
| Manieu Alexandre Weinstein | Director |
Apr 28 '25 |
Buy |
4.61 |
976,139 |
4,500,001 |
931,246 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):